2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on mNSCLC: Will the Efficacy of T-DXd in HER2+ Disease Add HER2 Mutation to the List of Essential NSCLC Biomarkers? OS With Bevacizumab + Erlotinib in EGFR+ NSCLC - Does It Change the Role of Osimertinib in 1L Therapy?

80 views
September 25, 2020
0 Comments
Login to view comments. Click here to Login